AdaptHealth Corp. (AHCO)
- Previous Close
9.48 - Open
9.67 - Bid 9.39 x 100
- Ask 9.52 x 100
- Day's Range
9.43 - 9.76 - 52 Week Range
6.37 - 15.37 - Volume
78,608 - Avg. Volume
968,361 - Market Cap (intraday)
1.261B - Beta (5Y Monthly) 1.14
- PE Ratio (TTM)
-- - EPS (TTM)
-5.27 - Earnings Date Aug 6, 2024 - Aug 12, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
11.95
AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.
adapthealth.comRecent News: AHCO
Performance Overview: AHCO
Trailing total returns as of 6/3/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AHCO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AHCO
Valuation Measures
Market Cap
1.26B
Enterprise Value
3.53B
Trailing P/E
--
Forward P/E
14.12
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.39
Price/Book (mrq)
0.86
Enterprise Value/Revenue
1.09
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-21.45%
Return on Assets (ttm)
3.66%
Return on Equity (ttm)
-38.07%
Revenue (ttm)
3.25B
Net Income Avi to Common (ttm)
-695.41M
Diluted EPS (ttm)
-5.27
Balance Sheet and Cash Flow
Total Cash (mrq)
84.47M
Total Debt/Equity (mrq)
159.42%
Levered Free Cash Flow (ttm)
97.19M